Tata Memorial study finds Nimotuzumab increases survival in head and neck cancer Patients with head and neck cancer who received Nimotuzumab in combination with concurrent radiotherapy and cisplatin had a…
Biocon Biologics & Viatris receives approval for Semglee® Company is eligible for 12 months of first interchangeable exclusivity from the date of commercial launch
Companies ‘feel betrayed’ due to capping of COVID-19 vaccine price: Kiran Mazumdar Shaw Kiran Mazumdar Shaw asked, "If WHO has agreed to USD 3 per dose, why beat them down to USD 2?"
In post-COVID phase, India’s healthcare infrastructure can receive a major boost: Dr Jitendra Singh Top professionals of India, drawn from the medical fraternity, corporate hospital sector, leading research bodies and medical…
Primary healthcare can play key role in combating outbreaks like coronavirus: Kiran Mazumdar-Shaw Heaping praise on the primary healthcare system set up in the national capital by Arvind Kejriwal-led AAP government,…
Biocon Foundation wins ‘WHO –India Public Health Champion Award 2015’ Biocon recognised for outstanding contribution to public health by WHO – India